Literature DB >> 25707331

Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics.

Michael P Diamond1, Richard S Legro2, Christos Coutifaris3, Ruben Alvero4, Randal D Robinson5, Peter Casson6, Gregory M Christman7, Joel Ager8, Hao Huang9, Karl R Hansen10, Valerie Baker11, Rebecca Usadi12, Aimee Seungdamrong13, G Wright Bates14, R Mitchell Rosen15, Daniel Haisonleder16, Stephen A Krawetz8, Kurt Barnhart3, J C Trussell17, Yufeng Jin9, Nanette Santoro4, Esther Eisenberg18, Heping Zhang9.   

Abstract

OBJECTIVE: To identify baseline characteristics of women with unexplained infertility to determine whether treatment with an aromatase inhibitor will result in a lower rate of multiple gestations than current standard ovulation induction medications.
DESIGN: Randomized, prospective clinical trial.
SETTING: Multicenter university-based clinical practices. PATIENT(S): A total of 900 couples with unexplained infertility. INTERVENTION(S): Collection of baseline demographics, blood samples, and ultrasonographic assessments. MAIN OUTCOME MEASURE(S): Demographic, laboratory, imaging, and survey characteristics. RESULT(S): Demographic characteristics of women receiving clomiphene citrate (CC), letrozole, or gonadotropins for ovarian stimulation were very consistent. Their mean age was 32.2 ± 4.4 years and infertility duration was 34.7 ± 25.7 months, with 59% primary infertility. More than one-third of the women were current or past smokers. The mean body mass index (BMI) was 27 and mean antimüllerian hormone level was 2.6; only 11 women (1.3%) had antral follicle counts of <5. Similar observations were identified for hormonal profiles, ultrasound characterization of the ovaries, semen parameters, and quality of life assessments in both male and female partners. CONCLUSION(S): The cause of infertility in the couples recruited to this treatment trial is elusive, as the women were regularly ovulating and had evidence of good ovarian reserve both by basal FSH, antimüllerian hormone levels, and antral follicle counts; the male partners had normal semen parameters. The three treatment groups have common baseline characteristics, thereby providing comparable patient populations for testing the hypothesis that use of letrozole for ovarian stimulation can reduce the rates of multiples from that observed with gonadotropin and CC treatment. CLINICAL TRIAL REGISTRATION NUMBER: NCT 01044862.
Copyright © 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Unexplained infertility; aromatase inhibitors; clomiphene citrate; gonadotropins; letrozole; multiple gestations

Mesh:

Substances:

Year:  2015        PMID: 25707331      PMCID: PMC4529113          DOI: 10.1016/j.fertnstert.2014.12.130

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  29 in total

1.  The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.

Authors:  R Rosen; C Brown; J Heiman; S Leiblum; C Meston; R Shabsigh; D Ferguson; R D'Agostino
Journal:  J Sex Marital Ther       Date:  2000 Apr-Jun

2.  The Pregnancy in Polycystic Ovary Syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial.

Authors:  Richard S Legro; Robert G Brzyski; Michael P Diamond; Christos Coutifaris; William D Schlaff; Ruben Alvero; Peter Casson; Gregory M Christman; Hao Huang; Qingshang Yan; Daniel J Haisenleder; Kurt T Barnhart; G Wright Bates; Rebecca Usadi; Richard Lucidi; Valerie Baker; J C Trussell; Stephen A Krawetz; Peter Snyder; Dana Ohl; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Fertil Steril       Date:  2013-10-21       Impact factor: 7.329

3.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

4.  Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial.

Authors:  Michael P Diamond; Mohamed Mitwally; Robert Casper; Joel Ager; Richard S Legro; Robert Brzyski; Peter Casson; Esther Eisenberg; Heping Zhang
Journal:  Contemp Clin Trials       Date:  2011-07-20       Impact factor: 2.226

5.  Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial.

Authors:  Pieternel Steures; Jan Willem van der Steeg; Peter G A Hompes; J Dik F Habbema; Marinus J C Eijkemans; Frank J Broekmans; Harold R Verhoeve; Patrick M M Bossuyt; Fulco van der Veen; Ben W J Mol
Journal:  Lancet       Date:  2006-07-15       Impact factor: 79.321

6.  Letrozole vs. clomiphene citrate in patients with ovulatory infertility.

Authors:  Ulkü Bayar; H Alper Tanriverdi; Aykut Barut; Ferruh Ayoğlu; Oya Ozcan; Erdal Kaya
Journal:  Fertil Steril       Date:  2006-03-09       Impact factor: 7.329

7.  A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.

Authors:  Richard H Reindollar; Meredith M Regan; Peter J Neumann; Bat-Sheva Levine; Kim L Thornton; Michael M Alper; Marlene B Goldman
Journal:  Fertil Steril       Date:  2009-06-16       Impact factor: 7.329

8.  Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler.

Authors:  Jinee Baruah; K K Roy; S M Rahman; Sunesh Kumar; J B Sharma; Debjyoti Karmakar
Journal:  Arch Gynecol Obstet       Date:  2008-07-03       Impact factor: 2.344

9.  The fertility quality of life (FertiQoL) tool: development and general psychometric properties.

Authors:  Jacky Boivin; Janet Takefman; Andrea Braverman
Journal:  Hum Reprod       Date:  2011-06-10       Impact factor: 6.918

10.  The Fertility Quality of Life (FertiQoL) tool: development and general psychometric properties.

Authors:  Jacky Boivin; Janet Takefman; Andrea Braverman
Journal:  Fertil Steril       Date:  2011-04-01       Impact factor: 7.490

View more
  21 in total

1.  Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility.

Authors:  Aaron K Styer; Susan Jin; Dan Liu; Baisong Wang; Alex J Polotsky; Mindy S Christianson; Wendy Vitek; Lawrence Engmann; Karl Hansen; Robert Wild; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Alicia Christy; Michael P Diamond; Esther Eisenberg; Heping Zhang; Nanette Santoro
Journal:  Fertil Steril       Date:  2017-01-12       Impact factor: 7.329

2.  Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility.

Authors:  Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter A Casson; Gregory M Christman; Hao Huang; Karl R Hansen; Valerie Baker; Rebecca Usadi; Aimee Seungdamrong; G Wright Bates; R Mitchell Rosen; William Schlaff; Daniel Haisenleder; Stephen A Krawetz; Kurt Barnhart; J C Trussell; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Am J Obstet Gynecol       Date:  2017-04-26       Impact factor: 8.661

3.  Fertility Related Quality of Life, Gonadal Function and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility.

Authors:  R Matthew Coward; Christy Stetter; Allen Kunselman; J C Trussell; Mark C Lindgren; Ruben R Alvero; Peter Casson; Gregory M Christman; Christos Coutifaris; Michael P Diamond; Karl R Hansen; Stephen A Krawetz; Richard S Legro; Randal D Robinson; James F Smith; Anne Z Steiner; Robert A Wild; Heping Zhang; Nanette Santoro
Journal:  J Urol       Date:  2019-07-08       Impact factor: 7.450

4.  Lower prevalence of non-cavity-distorting uterine fibroids in patients with polycystic ovary syndrome than in those with unexplained infertility.

Authors:  Hao Huang; Hongying Kuang; Fangbai Sun; Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter R Casson; Gregory M Christman; Karl R Hansen; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Fertil Steril       Date:  2019-03-27       Impact factor: 7.329

5.  Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.

Authors:  Nanette Santoro; Esther Eisenberg; J C Trussell; LaTasha B Craig; Clarisa Gracia; Hao Huang; Ruben Alvero; Peter Casson; Gregory Christman; Christos Coutifaris; Michael Diamond; Susan Jin; Richard S Legro; Randal D Robinson; William D Schlaff; Heping Zhang
Journal:  Hum Reprod       Date:  2016-07-07       Impact factor: 6.918

6.  Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.

Authors:  Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Joel Ager; Hao Huang; Karl R Hansen; Valerie Baker; Rebecca Usadi; Aimee Seungdamrong; G Wright Bates; R Mitchell Rosen; Daniel Haisenleder; Stephen A Krawetz; Kurt Barnhart; J C Trussell; Dana Ohl; Yufeng Jin; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

7.  Distinctive Reproductive Phenotypes in Peripubertal Girls at Risk for Polycystic Ovary Syndrome.

Authors:  Laura C Torchen; Richard S Legro; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

8.  Pregnancy registry: three-year follow-up of children conceived from letrozole, clomiphene, or gonadotropins.

Authors:  Richard S Legro; Michael P Diamond; Christos Coutifaris; William D Schlaff; Ruben Alvero; Peter Casson; Gregory M Christman; R Mitchell Rosen; Marcelle I Cedars; Karl R Hansen; Randal Robinson; Valerie Baker; Rebecca Usadi; William C Dodson; Stephanie J Estes; Allen Kunselman; Christina Stetter; Kurt T Barnhart; R Matthew Coward; J C Trussell; Stephen A Krawetz; Nanette Santoro; Hao Huang; Heping Zhang; Esther Eisenberg
Journal:  Fertil Steril       Date:  2020-05       Impact factor: 7.329

9.  Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility.

Authors:  Karl R Hansen; Esther Eisenberg; Valerie Baker; Micah J Hill; Sixia Chen; Sara Talken; Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter Casson; Gregory M Christman; Nanette Santoro; Heping Zhang; Robert A Wild
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

10.  Androgenicity and fertility treatment in women with unexplained infertility.

Authors:  Erica T Wang; Michael P Diamond; Ruben Alvero; Peter Casson; Gregory M Christman; Christos Coutifaris; Karl R Hansen; Fangbai Sun; Richard S Legro; Randal D Robinson; Rebecca S Usadi; Margareta D Pisarska; Nanette F Santoro; Heping Zhang
Journal:  Fertil Steril       Date:  2020-03       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.